Article
The IIF designation was added to include cystic lesions that are slightly more complex than category II, but that do not fulfill criteria of category III.
Enrollment goal met in phase 3 SOLAR-RECUR trial
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
FDA accepts sNDA for darolutamide plus ADT in mHSPC
Key updates from the AUA/ASRM male infertility guideline amendment
Phase 1/2 trial launches of CAR T cell therapy for ccRCC
Dean Laganosky, M.D., named Urology Trailblazer for 2024